KKR completes $5.7 billion acquisition of Integer Holdings

KKR completed its $5.7 billion acquisition of Integer Holdings (NYSE:ITGR), paying $127 per share. Integer's stock ceased trading on the NYSE. The medical device company will now operate under KKR's ownership, aiming to accelerate growth and invest in capabilities.

Original reporting
Published Nov 17, 2026, 2:04 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 17, 2026, 2:20 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefMergers & acquisitions
Primary signal
$ITGR
Bullish
high confidence
Mentioned
$ITGR
Relevance
8/10
AlphAI data visualization · based on investing.com
Decision brief

The 30-second read

$ITGRBullishMed
01

Why it matters

Completion at ~$5.7B enterprise value and $127/share cash consideration effectively ends public equity exposure to Integer’s standalone operating trajectory.

02

Market read

For ITGR, the key tradable event is the close and delisting, which typically reduces liquidity and removes equity upside/downside beyond deal mechanics.

03

What to watch

Traders may still need to monitor any residual settlement timing, escrow/earnout terms, or tax/withholding mechanics that can affect final cash receipt timing for holders.

Relevance 8/10Novelty 7/10Timing: deal close and delisting after shareholder approval

Background

KKR announced the acquisition on Aug. 3, 2026; Integer stockholders approved it on Oct. 21, 2026.

Company-level read

Ticker impact

$ITGRBullishHigh confidence
Context

Integer completed KKR’s ~$5.7B acquisition, receiving $127/share cash, and its NYSE listing ended after deal close.

Expected impact

Likely limited upside after delisting, with any remaining trading activity reflecting final deal mechanics rather than fundamentals.

Evidence & confidence

The article states the acquisition is completed, cash consideration per share is set, and the common stock ceased trading and is no longer listed.

Market effects

Medical device CDMO M&A remains active; deal completion can tighten near-term acquisition supply for similar contract manufacturers.

Limited broader regional impact expected beyond healthcare M&A sentiment.

Moderate global PE activity signal in medtech manufacturing services, but not a macro driver.

Counterpoint

Because the deal was already announced and approved, the incremental trading impact may be mostly mechanical rather than signaling new valuation upside.

Key entities

  • Integer Holdings Corporation

    Medical device contract development and manufacturing organization (CDMO) serving cardio and vascular and related markets.

  • KKR

    Global investment firm completing the acquisition and integrating Integer into its portfolio.

  • Payman Khales

    Integer President and CEO quoted on the post-close strategy.

  • Max Lin

    KKR Partner quoted on welcoming Integer into the portfolio.

Related articles

$ITGRHighAI 9/10

Integer Secures $2.45 Billion Credit Facility to Finance $5.4 Billion Merger

Integer Holdings (ITGR) secured a $2.45 billion credit facility, including a $2.1 billion term loan and up to $350 million revolving credit, to finance a $5.4 billion merger. The company also amended its 2028 and 2030 convertible notes to reflect a $127-per-share cash consideration. Integer repaid and terminated its 2021 credit agreement and capped call transactions related to both note issues, with undisclosed cash payments received.

$ITGRMed

Integer Holdings Corp (ITGR): Completion of Acquisition or Disposition of Assets

Integer Holdings Corp (ITGR) filed an SEC Form 8-K — Completion of Acquisition or Disposition of Assets. Exhibit 99.1 FOR IMMEDIATE RELEASE Integer Holdings Corporation Provides Notice of Make-Whole Fundamental Change, Fundamental Change and Right to Convert to Holders of its 2.125% Convertible Senior Notes due 2028 and 1.875% Convertible Senior Notes due 2030 in Connection with Com

$ITGRMed

Integer noteholders receive conversion terms following merger

Integer Holdings Corporation completed its merger with Armstrong Bidco Inc., triggering conversion rights for holders of its 2.125% Convertible Senior Notes due 2028 and 1.875% Convertible Senior Notes due 2030. Noteholders can convert their securities until January 8, 2027, receiving enhanced rates during the make-whole period. The company is not required to repurchase the notes due to the merger's cash-only nature.

$SITEMed

SiteOne Landscape Supply to Replace Integer Holdings in S&P SmallCap 600

S&P Dow Jones Indices announced SiteOne Landscape Supply (SITE) will replace Integer Holdings in the S&P SmallCap 600 on November 19, 2026. The change follows KKR's pending acquisition of Integer for $127 per share. SiteOne reported Q3 2026 net sales of $1.29 billion, up 3% YoY, with acquisitions driving growth. Gross margin expanded to 35.5%, and net income rose 8% to $63.9 million. The company plans to increase its share repurchase program by $500 million.